Sharps Compliance Corp. (NASDAQ:SMED) Director John W. Dalton sold 10,000 shares of the stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $7.40, for a total transaction of $74,000.00. Following the completion of the sale, the director now directly owns 943,338 shares of the company’s stock, valued at $6,980,701.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
SMED traded up $0.05 during midday trading on Wednesday, reaching $7.65. The company’s stock had a trading volume of 89,158 shares, compared to its average volume of 223,146. The stock has a market cap of $125.28 million, a P/E ratio of 58.85, a PEG ratio of 2.89 and a beta of -0.61. The company has a fifty day simple moving average of $7.69 and a 200 day simple moving average of $6.89. The company has a current ratio of 1.83, a quick ratio of 1.41 and a debt-to-equity ratio of 0.34. Sharps Compliance Corp. has a twelve month low of $3.74 and a twelve month high of $8.99.
Sharps Compliance (NASDAQ:SMED) last announced its quarterly earnings data on Wednesday, August 19th. The industrial products company reported $0.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.12. Sharps Compliance had a net margin of 4.43% and a return on equity of 8.11%. During the same period in the prior year, the business earned $0.03 EPS. Sell-side analysts expect that Sharps Compliance Corp. will post 0.11 earnings per share for the current year.
SMED has been the topic of several analyst reports. Zacks Investment Research upgraded shares of Sharps Compliance from a “sell” rating to a “hold” rating in a research note on Thursday, August 27th. Barrington Research reissued a “buy” rating and set a $9.00 price objective on shares of Sharps Compliance in a report on Friday, August 21st. TheStreet upgraded Sharps Compliance from a “c” rating to a “b” rating in a report on Friday, August 21st. Finally, Lake Street Capital initiated coverage on Sharps Compliance in a report on Wednesday, July 15th. They set a “buy” rating and a $10.00 price target on the stock. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $8.25.
Sharps Compliance Company Profile
Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.
Recommended Story: What’s a Black Swan?
Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.